New Fib-3 Index Outperforms Age-Based Models for Liver Fibrosis in Seniors

The Fib-3 index demonstrates superior accuracy in predicting liver fibrosis and long-term outcomes in hepatocellular carcinoma patients over 65. An independent risk factor for recurrence-free survival, it outshines the conventional Fib-4 index by eliminating age-related biases. Effective risk stratification for 5-year survival hinges on its application alongside specific cutoff values, positioning the Fib-3 index as a vital tool in managing elderly patients post-hepatectomy.